SCHEMBL2199023

SCHEMBL2199023

COc1cc(OC)nc(NCc2c(-c3ccc(Cl)cc3)nc3ccc(Cl)cn23)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.55
SLC2A1 P11166 8/20 0.52
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
PSMD14 O00487 1/20 0.51
MMP2 P08253 1/20 0.51
KDM4E B2RXH2 3/20 0.50
HTT P42858 2/20 0.50
GAA P10253 2/20 0.49
MAPT P10636 1/20 0.49
RAB9A P51151 1/20 0.49
TSPO P30536 2/20 0.47
CASP1 P29466 1/20 0.47
CASP7 P55210 1/20 0.47
HSD17B10 Q99714 1/20 0.47
NR1I2 O75469 1/20 0.47
ABCB11 O95342 1/20 0.47
ALB P02768 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
ADORA1 P30542 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2196937 0.94 ALDH1A1 (0.51) ALDH1A1SLC2A1MEN1KMT2APSMD14
SCHEMBL2194773 0.85 ALDH1A1 (0.58) ALDH1A1SLC2A1MEN1KMT2APSMD14
SCHEMBL1430086 0.82 ALDH1A1 (0.55) ALDH1A1SLC2A1MEN1KMT2APSMD14
SCHEMBL2197211 0.80 ALDH1A1 (0.57) ALDH1A1SLC2A1MEN1KMT2AKDM4E
SCHEMBL1430096 0.79 SIRT5 (0.56) ALDH1A1SLC2A1MEN1KMT2APSMD14
Hydrochloric Acid SCHEMBL1432745 0.79 ALDH1A1 (0.56) ALDH1A1SLC2A1MEN1KMT2AKDM4E
SCHEMBL1430089 0.78 SLC2A1 (0.52) ALDH1A1SLC2A1PSMD14MMP2GAA
SCHEMBL12411232 0.78 PSMD14 (0.52) ALDH1A1SLC2A1MEN1KMT2APSMD14
SCHEMBL2199788 0.77 ALDH1A1 (0.55) ALDH1A1SLC2A1MEN1KMT2APSMD14
SCHEMBL1427821 0.76 SIRT5 (0.51) ALDH1A1SLC2A1MEN1KMT2APSMD14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130289013-A1 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS SUNOVION PHARMACEUTICALS INC. 2013-10-31 US disclosed
US-8497278-B2 Imidazo[1,2-a]pyridine compounds SUNOVION PHARMACEUTICALS INC. (US) 2013-07-30 US disclosed
US-20110166146-A1 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS SUNOVION PHARMACEUTICALS INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166146-A1 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS PAICS, ITPA, DPYD ALDH1A1 269/4885SLC2A1 2033/4885MEN1 1720/4885
US-20130289013-A1 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS PAICS, ITPA, DPYD ALDH1A1 269/4885SLC2A1 2033/4885MEN1 1720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.